Non-alcoholic fatty liver disease fibrosis score and FIB-4 scoring system could identify patients at risk of systemic complications. (Q50462093)

http://europepmc.org/abstract/MED/25145976

14 March 2018

title

Non-alcoholic fatty liver disease fibrosis score and FIB-4 scoring system could identify patients at risk of systemic complications. (English)

1 reference

http://europepmc.org/abstract/MED/25145976

14 March 2018

main subject

metabolic dysfunction–associated steatotic liver disease

1 reference

based on heuristic

inferred from title

non-alcoholic fatty liver

1 reference

Yuka Takahashi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25145976%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Masayuki Kurosaki

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25145976%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Yutaka Yasui

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25145976%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Takanori Hosokawa

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25145976%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Kaoru Tsuchiya

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25145976%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Hiroyuki Nakanishi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25145976%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Jun Itakura

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25145976%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

publication date

15 October 2014

1 reference

http://europepmc.org/abstract/MED/25145976

14 March 2018

published in

Hepatology Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25145976%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25145976%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25145976%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

page(s)

667-675

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25145976%20AND%20SRC:MED&resulttype=core&format=json

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

5 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12405

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12405

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12405

Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12405

Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12405

Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12405

The metabolic syndrome: common origins of a multifactorial disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12405

Metabolic syndrome and cardiac disease in Japanese men: applicability of the concept of metabolic syndrome defined by the National Cholesterol Education Program-Adult Treatment Panel III to Japanese men--the Tanno and Sobetsu Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12405

Significance of the presence of metabolic syndrome in patients with asymptomatic arteriosclerosis affecting the aorta and the cerebral, extra-cranial carotid and coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12405

Impact of non-alcoholic fatty liver disease on accelerated metabolic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12405

Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12405

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12405

Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12405

Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12405

21 January 2018

Identifiers

DOI

10.1111/HEPR.12405

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25145976%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

1 reference